Roth David
Officer at SYRS
- Sold, on record
- $140k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Nov 18, 2024
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SYRSSyros Pharmaceuticals, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SYRSNoticeDec 12, 2023 2023
Filed to sell 6,287 shares ($31k)
Roth David, Officer
10b5-1 planFiling
- 2 Form 4 sale SYRSRoutineDec 12, 2023 same day
Sold 6,287 shares at $4.95 ($31k)
Roth David, Chief Medical Officer
10b5-1 planSold 100% of holdings ($31k position)0 shares leftFollows a Form 144Filing
- 3 Form 144 notice SYRSNoticeApr 2, 2024 +112 days
Filed to sell 150 shares ($747)
Roth David, Officer
10b5-1 plan0x usual sizeFiling
- 4 Form 4 sale SYRSRoutineApr 2, 2024 same day
Sold 150 shares at $4.98 ($747)
Roth David, Chief Medical Officer
10b5-1 planSold 1.4% of holdings ($53k position)10,451 shares left0x usual sizeFollows a Form 144Filing
- 5 Form 144 notice SYRSNoticeApr 3, 2024 +1 day
Filed to sell 10,451 shares ($52k)
Roth David, Officer
10b5-1 plan1.7x usual sizeFiling
- 6 Form 4 sale SYRSRoutineApr 3, 2024 same day
Sold 10,451 shares at $4.95 ($52k)
Roth David, Chief Medical Officer
10b5-1 planSold 100% of holdings ($52k position)0 shares left1.7x usual sizeFollows a Form 144Filing
- 7 Form 144 notice SYRSNoticeNov 18, 2024 +229 days
Filed to sell 12,099 shares ($2k)
Roth David, Officer
No 10b5-1 plan1.9x usual sizeFiling
- 8 Form 4 sale SYRSUnusualNov 18, 2024 same day
Sold 12,099 shares at $0.20 ($2k)
Roth David, Chief Medical Officer
No 10b5-1 planSold 100% of holdings ($2k position)0 shares left1.9x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Nov 20, 2024 | SYRS | Chief Medical Officer | Form 4 sale | 12,099 | $2k | 100.0% | Unusual | SEC |
| Nov 18, 2024 | Nov 18, 2024 | SYRS | Officer | Form 144 notice | 12,099 | $2k | Notice | SEC | |
| Apr 3, 2024 | Apr 5, 2024 | SYRS | Chief Medical Officer | Form 4 sale | 10,451 | $52k | 100.0% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | SYRS | Officer | Form 144 notice | 10,451 | $52k | Notice | SEC | |
| Apr 2, 2024 | Apr 2, 2024 | SYRS | Chief Medical Officer | Form 4 sale | 150 | $747 | 1.4% | Routine | SEC |
| Apr 2, 2024 | Apr 2, 2024 | SYRS | Officer | Form 144 notice | 150 | $747 | Notice | SEC | |
| Dec 12, 2023 | Dec 14, 2023 | SYRS | Chief Medical Officer | Form 4 sale | 6,287 | $31k | 100.0% | Routine | SEC |
| Dec 12, 2023 | Dec 12, 2023 | SYRS | Officer | Form 144 notice | 6,287 | $31k | Notice | SEC | |
| Dec 6, 2023 | Dec 8, 2023 | SYRS | Chief Medical Officer | Form 4 sale | 6,287 | $25k | 50.0% | Routine | SEC |
| Dec 6, 2023 | Dec 6, 2023 | SYRS | Officer | Form 144 notice | 6,287 | $25k | Notice | SEC | |
| Jul 31, 2023 | Aug 2, 2023 | SYRS | Chief Medical Officer | Form 4 sale | 7,348 | $29k | 100.0% | Routine | SEC |
| Jul 31, 2023 | Jul 31, 2023 | SYRS | Officer, Chief Medical Officer | Form 144 notice | 7,348 | $29k | Notice | SEC |